GLP-1 drugs have changed the lives of Americans and others across the world, in ways both expected and unexpected. Originally used to help people with Type 2 diabetes manage their blood sugar levels, GLP-1 drugs have achieved a widespread level of popularity and notoriety as weight-loss medicines over the past half-decade. The drugs, which include brands like Novo Nordisk's Wegovy and Eli Lilly and Company's Zepbound, essentially mimic gut hormones to function as appetite suppressants. Roughly